Oracle Application Testing Suite 13.3.0.1 OpenScript privileges management
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 8.1 | $0-$5k | 0.00 |
Summary
A vulnerability categorized as very critical has been discovered in Oracle Application Testing Suite 13.3.0.1. This affects an unknown function of the component OpenScript. The manipulation results in privileges management. This vulnerability is cataloged as CVE-2026-101549. The attack must be initiated from a local position. There is no exploit available. It is advisable to upgrade the affected component.
Details
A vulnerability, which was classified as very critical, was found in Oracle Application Testing Suite 13.3.0.1. Affected is an unknown functionality of the component OpenScript. The manipulation with an unknown input leads to a privileges management vulnerability. CWE is classifying the issue as CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. This is going to have an impact on confidentiality, integrity, and availability. CVE summarizes:
Vulnerability in Oracle Application Testing Suite (component: OpenScript). The supported version that is affected is 13.3.0.1. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Oracle Application Testing Suite executes to compromise Oracle Application Testing Suite. Successful attacks of this vulnerability can result in takeover of Oracle Application Testing Suite. CVSS 3.1 Base Score 7.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).
The advisory is available at oracle.com. This vulnerability is traded as CVE-2026-101549 since 09/28/2026. The exploitability is told to be easy. Local access is required to approach this attack. The technical details are unknown and an exploit is not available. The structure of the vulnerability defines a possible price range of USD $0-$5k at the moment (estimation calculated on 10/21/2026). This vulnerability is assigned to T1068 by the MITRE ATT&CK project.
Upgrading eliminates this vulnerability.
If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 8.3VulDB Meta Temp Score: 8.1
VulDB Base Score: 8.8
VulDB Temp Score: 8.4
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 7.8
CNA Vector (oracle): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: Partially
Local: Yes
Remote: No
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Timeline
09/28/2026 CVE reserved10/20/2026 VulDB entry created
10/21/2026 Advisory disclosed
10/21/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-101549 (🔒)
GCVE (CVE): GCVE-0-2026-101549
GCVE (VulDB): GCVE-100-423354
Entry
Created: 10/21/2026 01:21Changes: 10/21/2026 01:21 (65)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.